Schedule Appointment

Oklahoma’s Medical Cannabis Accused of Exaggerated THC Potency: Testing Lab Rings Alarm Bells

Guide Navigation

Lab Reports Inflated THC Potency in Oklahoma’s Medical Cannabis

A recent revelation from Havard Industries, a licensed lab in Oklahoma, suggests that the potency of medical cannabis in the state is often overstated. As one of the entities authorized to check the quality of cannabis products in the state, Havard Industries has hinted at discrepancies in the reported THC potency of Oklahoma’s medical cannabis.

Mike Johnson, the manager of Havard Industries, expressed concerns about the inconsistency between the advertised potency levels and the actual levels which his lab has documented. “It’s concerning that consumers may not be getting the level of medication they believe they are,” said Johnson.

Understanding THC Potency

Tetrahydrocannabinol (THC) is the psychoactive compound in cannabis that produces the “high” typically associated with marijuana use. THC potency is typically expressed as a percentage of the drug’s weight. It’s important for medical cannabis users to know the potency of their product, as it helps in proper dosing and achieving the desired effects.

Implication of Overstated THC Levels

The implication of inflated THC potency labels on patients can be quite significant. Patients who rely on these potency levels to adjust their dosage may not get the desired effect or relief they expect from the cannabis medicine due to lower-than-advertised potency.

Explore Other Viable Medical Cannabis Options

Despite the uncertainty surrounding Oklahoma’s medical cannabis potency, patients in need of relief should not be discouraged. It is crucial for patients and healthcare providers to consider other options or regions that have stricter regulations and a more transparent medical cannabis program. As a renowned facilitator of medical marijuana cards, MMJ.com assists patients in obtaining or renewing their medical marijuana cards in various U.S states, ensuring they have legal access to quality, tested cannabis medicine.

Moving Forward: Transparency and Accuracy

In response to Havard Industries’ findings, there’s a call for more transparency and accuracy in testing and labeling cannabis products. mmj.com is dedicated to providing correct and updated information to both new patients and those seeking renewals of their medical marijuana cards.

Overall, in the era of medical marijuana expansion, it’s essential that accurate information and guidelines be available to ensure patients get the quality of medication they need. mmj.com remains committed to serving patients and ensuring they receive effective, quality-assured medication without the uncertainties surrounding potency accuracy.

Share This Post:
Article Info
Content Last Updated: March 28, 2024
Latest News
  • January 15, 2025

    Pennsylvania's Medical Marijuana Program, established under the Medical Marijuana Act of 2016, provides patients with serious medical conditions access to medical cannabis. This article explores the program’s up-to-date qualifying conditions, how cannabis can benefit patients, and how to obtain a medical marijuana card through MMJ.com. Qualifying Conditions for Medical Marijuana in Pennsylvania What Are the…

  • January 15, 2025

    West Virginia’s medical marijuana program, established under the Medical Cannabis Act of 2017, provides access to medical cannabis for patients with qualifying conditions. This program offers a natural treatment option for residents seeking relief from chronic and debilitating conditions. Below, we explore the program’s qualifying conditions, how cannabis can help, and how to get a…

  • January 14, 2025

    The Illinois medical marijuana program has expanded, offering relief and new treatment options for more patients. Recently, the state has added four medical conditions to its qualifying list, further cementing the program’s dedication to supporting patient health and wellness. For Illinois residents seeking to understand these changes, this article explores the newly added conditions, their…

  • New York Medical Marijuana Card
    January 13, 2025

    Chronic pain is one of the most common reasons patients seek medical cannabis. With its prevalence affecting millions of individuals worldwide, chronic pain poses significant challenges for traditional medicine. Medical cannabis, particularly its active compounds THC (tetrahydrocannabinol) and CBD (cannabidiol), has emerged as a promising alternative for managing pain. This report examines the evidence, mechanisms,…

  • January 13, 2025

    Chemotherapy-induced nausea and vomiting (CINV) are among the most distressing side effects of cancer treatment, significantly impacting patients' quality of life. While advancements in antiemetic therapies have improved symptom management, a substantial number of patients experience refractory CINV that is unresponsive to standard treatments. Medical cannabis, particularly its cannabinoid compounds THC (tetrahydrocannabinol) and CBD (cannabidiol),…

  • January 11, 2025

    Cannabis legalization has been a topic of significant debate and transformation in the United States over the past decade. As of 2025, a majority of states have legalized cannabis in some form, either for medical or recreational use. However, federal legalization remains elusive, with cannabis classified as a Schedule I substance under the Controlled Substances…

  • January 11, 2025

    Cannabis has long been classified as a Schedule I substance under the Controlled Substances Act (CSA), alongside drugs like heroin and LSD. This classification indicates a high potential for abuse and no accepted medical use. However, recent developments suggest a shift may be on the horizon. In 2024, the Department of Health and Human Services…

  • January 8, 2025

    Sleep disorders affect millions of people worldwide, leading to significant impacts on physical and mental health. As research into medical cannabis continues to evolve, many patients are exploring its potential as a sleep aid. Cannabinoids such as THC, CBD, and CBN have shown promise in addressing various sleep-related issues. This report delves into the science…

  • January 8, 2025

    Ohio’s medical cannabis program has seen rapid growth and significant developments, providing more patients with access to safe and regulated cannabis for therapeutic use. With expanding dispensary networks, rising sales, and legislative advancements, Ohio is becoming a model state for medical cannabis. This article explores Ohio’s medical marijuana program and highlights how patients can schedule…

  • January 8, 2025

    Georgia’s medical cannabis program has made significant strides in recent years, expanding access and refining its regulatory framework. With ongoing legislative efforts, pharmacy integration, and patient registry growth, the program is set to offer more opportunities for patients. This article provides a comprehensive overview of Georgia’s medical cannabis landscape and explains how patients can obtain…

  • January 7, 2025

    Louisiana’s medical cannabis program has grown significantly since its establishment, providing patients with access to therapeutic cannabis for various health conditions. This article explores the development of Louisiana’s medical marijuana industry, focusing on how patients can obtain a medical marijuana card and connect with certified medical marijuana doctors through platforms like MMJ.com. What is Louisiana’s…

  • January 6, 2025

    The world of cannabinoids goes far beyond THC and CBD. Compounds like CBN, CBG, and CBC are gaining attention for their unique properties and potential health benefits. This article delves into the science behind these cannabinoids, focusing on their effects and medical research supporting their use. What Are Cannabinoids? Cannabinoids are found in medical cannabis.…

Read More